“…Regarding adherens junctions, reduced VEcadherin/β-catenin expression in dilated cardiomyopathy was associated with endothelial cell degeneration, 60 whereas in post-ischaemic MO, Src inhibition prevented VEGF-mediated disruption of Flk/VE-cadherin/β-catenin complex and attenuated post-ischaemic MO, fibrosis and mortality. 61 In addition, key risk factors for HF development and progression have been shown experimentally to promote endothelial hyperpermeability by disrupting EIJ, namely, renin-angiotensin-aldosterone system activation, 62 inflammation, 63,64 hypoxia, 65 cardioplegic arrest, 66 hyperglycaemia, 67 oxidative stress, 68 increased circulating LDL 69,70 and free fatty acid 71 levels.…”